InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
4
已披露卖出
0
T+90 胜率
50%
T+90 平均收益
+1.2%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Cox Carrie Smith. Director active across 7 companies, notably CARDINAL HEALTH INC. Cumulatively, 19 filings have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €712k. Activity tracked since 11 November 2021. The latest transaction was disclosed on 13 May 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Cox Carrie Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
4,306 股@ US$110.150.0002% mcap50.0% 占其流量Common StockSEC:0000097476-26-000137:0
4,916 股0Common StockSEC:0001110753-26-000004:0
6,336 股0Common StockSEC:0001110753-26-000002:0
525 股0Common StockSEC:0000097476-26-000044:0
65,400 股@ US$7.672182.8% 占其流量Common StockSEC:0001628280-25-052004:0
标准退出：2026年2月10日 (T+90)
5,148 股0Common StockSEC:0001628280-25-025969:0
12,469 股@ US$8.0673100.0% 占其流量Common StockSEC:0001821825-25-000037:0
标准退出：2025年8月12日 (T+90)
614 股0Common StockSEC:0001127602-25-002263:0
2,600 股0Common StockSEC:0001453687-25-000016:0
686 股0Common StockSEC:0001127602-24-002436:0
178,000 股0Common StockSEC:0001453687-24-000019:0
9,990 股@ US$52.9337.3% 占其流量Common StockSEC:0001127602-23-021922:0
574 股0Common StockSEC:0001127602-23-002679:0
2,308 股0Common SharesSEC:0000721371-22-000156:0
130,000 股@ US$1.152361.6% 占其流量Common StockSEC:0001453687-22-000104:0
标准退出：2022年9月11日 (T+90)
572 股0Common StockSEC:0001127602-22-002570:0
17,200 股@ US$2.945623.8% 占其流量Common StockSEC:0001453687-21-000162:0
标准退出：2022年3月3日 (T+90)
3,709 股0Common SharesSEC:0000721371-21-000132:0
1,889 股Common StockSEC:0001127602-16-038811:0
19 条申报中的 19 条
About Cox Carrie Smith
COX CARRIE SMITH has 19 filings in total. In the 19 most recent filings available, buy amounts stand at EUR 711613, sell amounts at EUR 0, and the period runs from 2016-02-01 to 2026-05-14. She is Director at Texas Instruments INC, Solventum Corp, Cartesian Therapeutics, Inc., CARDINAL HEALTH INC and Selecta Biosciences INC, and Executive Chair at Organon & Co.; the main recent filings concern Texas Instruments INC, Organon & Co., and Selecta Biosciences INC.
